Uremic Toxins and Outcomes in Chronic Kidney Disease
Status
Conditions
Details and patient eligibility
About
The aim of this cohort study is:
To investigate the etiology and epidemiology of comorbidities in CKD; To find out risk factors associated with the mortality of CKD; To find out uremic toxins which are related to the mortality and comorbidities of CKD; To focuse on the association between uremic toxins and inflammation, oxidative stress and nutritional status in CKD.
Full description
To investigate the etiology and epidemiology of comorbidities in CKD; To find out risk factors associated with the mortality of CKD; To find out uremic toxins which are related to the mortality and comorbidities of CKD; To focuse on the association between uremic toxins and inflammation, oxidative stress and nutritional status in CKD.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- age ≥18 years old;
- clinically diagnosed with chronic kidney disease, according K/DOQI criteria.
Exclusion criteria
- acute kidney injury
- history of kidney injury <3 months
- malignancy
- pregnancy
- incomplete clinical data
Trial design
500 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Wenji Wang, MD; Feng Ding, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal